CA 19-9 antibody (glycosylated)
Quick Overview for CA 19-9 antibody (glycosylated) (ABIN7824445)
Target
See all CA 19-9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- glycosylated
-
Purpose
- Anti-CA19-9/Sialyl Lewis A (sLeA) Antibody (BSA and Azide free)
-
Specificity
- No off-targets reported
-
Characteristics
- Our Anti-CA19-9/Sialyl Lewis A (sLeA) mouse monoclonal primary antibody is produced in-house from hybridoma clone CA19-9-203. It detects human CA19-9/Sialyl Lewis A (sLeA), and is purified by protein a chromatography. It is great for use in WB, IHC, ICC, ELISA.
-
Purification
- Produced by in vitro bioreactor culture of hybridoma line followed by Protein A affinity chromatography and buffer exchanged into 1X PBS. Purified mAbs are >90% specific antibody.
-
Purity
- Purified mAbs are >90 % specific antibody.
-
Immunogen
- Purified human mucin from ovarian cyst
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS7.4, carrier free
-
Preservative
- Azide free
-
Handling Advice
- For maximum recovery of product, centrifuge the vial prior to removing the cap.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Aliquot and store at ≤ -20°C for long term storage. For short term storage, store at 2-8°C.
-
Expiry Date
- 12 months
-
-
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
-
Alternative Name
- CA19-9/Sialyl Lewis A
-
Background
-
Synonyms: CA19-9, Sialyl Lewis A, sLeA
Description Logic: Our Anti-CA19-9/Sialyl Lewis A (sLeA) mouse monoclonal primary antibody is produced from hybridoma clone CA19-9-203. It detects human CA19-9/Sialyl Lewis A (sLeA), and is purified by protein a chromatography. It is great for use in WB, IHC, ICC, ELISA.
-
Molecular Weight
- 120-400 kDa
Target
-